Latest Headlines
-
Quest Diagnostics And Broad Clinical Labs To Evaluate Whole Genome Sequencing As First-Line Genetic Test For Developmental Delay
4/2/2024
Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, and Broad Clinical Labs, the world expert in whole genome sequencing (WGS), today announced a research collaboration designed to demonstrate the clinical value of WGS as a first-line genetic test for postnatal diagnosis of developmental delay disorders.
-
Agilent Launches New Advanced Dilution System To Increase Lab Efficiency
4/1/2024
Agilent Technologies Inc. today announced the launch of the Advanced Dilution System, the ADS 2, a new automation workflow solution that will increase productivity, lower cost of ownership, and improve the overall efficiency within the laboratory.
-
Grace Health Technology Launches New Laboratory Management Software
3/29/2024
Grace Health Technology, a leading provider of innovative software solutions for the healthcare industry, today announced the expansion of its laboratory-specific applications with the launch of a groundbreaking new application poised to revolutionize laboratory technology and enhance efficiency in healthcare settings.
-
DMEGC Solar's PV Test Center Obtains TÜV Rheinland Certification
3/29/2024
On March 19, DMEGC Solar received the Acknowledgement of Manufacturer's Laboratory Competence issued by TÜV Rheinland, a global certification agency, proving its excellence in PV module R&D and quality control.
-
Labcorp Announces Acquisition Of Select Assets Of BioReference Health's Diagnostics Business
3/28/2024
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO Health.
-
Dual 510(K) Clearance And CLIA-waiver Approval For The BIOFIRE SPOTFIRE R/ST Panel
3/27/2024
bioMérieux, a world leader in the field of in vitro diagnostics, has received U.S. Food and Drug Administration (FDA) 510(k) clearance and Clinical Laboratory Improvement Amendments (CLIA) waiver approval for the BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panel.
-
Bostongene Recognized As Designated Laboratory For The ComboMATCH Precision Medicine Clinical Trial
3/26/2024
BostonGene, a leading provider of AI-driven, molecular and immune profiling solutions, today announced its participation in the Molecular Analysis for Combination Therapy Choice (ComboMATCH) precision medicine initiative as a designated laboratory.
-
STEMCELL Technologies Announces FDA De Novo Classification For Its EasySep CD138 Positive Selection Kit To Support Cancer Diagnostic Tests
3/26/2024
STEMCELL Technologies is pleased to announce that its new EasySep Human Bone Marrow CD138 Positive Selection Kit has been granted de novo classification by the U.S. Food and Drug Administration (FDA) as a first-of-its-kind in vitro diagnostic (IVD) medical device for hematopoietic cell enrichment.
-
FormaPath Announces The Novel Tissue Biopsy Grossing Platform: nToto™
3/26/2024
In conjunction with a poster presentation at the United States and Canada Association of Pathologists Annual (USCAP) meeting titled "Current State of Intra-/Interobserver Accuracy and Reproducibility in Tissue Biopsy Grossing and Comparison to an Automated Vision System" – Poster #198, FormaPath is pleased to announce nToto, a new automated tissue visualization system (ATVS) developed in collaboration with Mayo Clinic's Advanced Diagnostics Laboratory.
-
Nucleus Genomics Launches To Bring Whole-Genome Sequencing To The Public
3/25/2024
Nucleus Genomics, the next-generation genetic testing and analysis company, today announced the launch of its DNA analysis product to bring the benefits of personalized medicine to everyone.